Bobak R. Azamian, President/CEO and Board Chair at Tarsus Pharmaceuticals, Inc. (TARS), sold 15,800 shares at $18.54 ($290K) on 2023-11-15, disclosed to the SEC on 2023-11-17.
Scheduled sale ($290k) by President/CEO and Board Chair under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.01 | 2,896 | $52K | 18.0% |
| 2 | $18.01 | 2,896 | $52K | 18.0% |
| 3 | $18.54 | 4,904 | $91K | 31.4% |
| 4 | $18.54 | 4,904 | $91K | 31.4% |
| 5 | $19.28 | 200 | $4K | 1.3% |
| Total | $18.36 avg | 15,800 |
| $290K |
| 100% |
| Filing → |
| TARS | SELL | 2026-06-22 | $615K | — | Filing → |
| TARS | SELL | 2026-03-19 | $2.4M | — | Filing → |
| TARS | SELL | 2025-12-30 | $944K | — | Filing → |